These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29529394)

  • 21. Prognostic value of plasma big endothelin-1 in patients with light chain cardiac amyloidosis.
    Chen Z; Shi A; Wang Z; Chen Y; Lin Y; Su M; Dong H; Laptseva N; Hu Y; Flammer AJ; Duru F; Jin W; Chen L
    Heart; 2024 Aug; 110(18):1124-1132. PubMed ID: 39084705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.
    Gonzalez M; Keating RJ; Markowitz SM; Liu CF; Thomas G; Ip JE; Lerman BB; Cheung JW
    Heart Rhythm; 2014 Dec; 11(12):2214-21. PubMed ID: 25131667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients.
    Yang S; Liu Z; Liu S; Ding L; Chen K; Hua W; Zhang S
    Clin Biochem; 2018 Sep; 59():25-30. PubMed ID: 29913121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECG Features Associated With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF-CHF Analysis.
    Andrade JG; Roy D; Wyse DG; Dorian P; Talajic M; Leduc H; Cadrin-Tourigny J; Shohoudi A; Macle L; Thibault B; Guerra PG; Rivard L; Dubuc M; Khairy P
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):404-13. PubMed ID: 27074775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study.
    Melduni RM; Schaff HV; Bailey KR; Cha SS; Ammash NM; Seward JB; Gersh BJ
    Am Heart J; 2015 Oct; 170(4):659-68. PubMed ID: 26386789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation.
    Cha MJ; Lee HS; Kim HM; Jung JH; Choi EK; Oh S
    Eur J Intern Med; 2017 Dec; 46():41-46. PubMed ID: 28781193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia.
    Cai Z; Wang H; Yuan S; Yin D; Song W; Dou K
    Front Cardiovasc Med; 2021; 8():768431. PubMed ID: 34912865
    [No Abstract]   [Full Text] [Related]  

  • 28. Anemia as an Independent Predictor of Adverse Cardiac Outcomes in Patients with Atrial Fibrillation.
    Lee WH; Hsu PC; Chu CY; Lee HH; Lee MK; Lee CS; Yen HW; Lin TH; Voon WC; Lai WT; Sheu SH; Su HM
    Int J Med Sci; 2015; 12(8):618-24. PubMed ID: 26283880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Heart Rhythm; 2015 Dec; 12(12):2368-75. PubMed ID: 26164377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
    Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
    Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma endothelin-1 level is a predictor of 10-year mortality in a general population: the Tanushimaru study.
    Yokoi K; Adachi H; Hirai Y; Enomoto M; Fukami A; Ogata K; Tsukagawa E; Kasahara A; Imaizumi T
    Circ J; 2012; 76(12):2779-84. PubMed ID: 22971991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
    Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation.
    Stoyanov KM; Giannitsis E; Biener M; Mueller-Hennessen M; Arens K; Katus HA; Vafaie M
    Europace; 2018 Apr; 20(4):582-588. PubMed ID: 28460039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
    Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma big endothelin-1 and stent thrombosis: An observational study in patients undergoing percutaneous coronary intervention in China.
    Chen Y; Li JX; Song Y; Xu JJ; Tang XF; Jiang L; Jiang P; Liu R; Wang HH; Zhao XY; Chen J; Gao Z; Qiao SB; Gao RL; Yang YJ; Xu B; Yuan JQ
    Thromb Res; 2017 Nov; 159():5-12. PubMed ID: 28942357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    Yonsei Med J; 2015 Jan; 56(1):62-71. PubMed ID: 25510748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Hijazi Z; Aulin J; Andersson U; Alexander JH; Gersh B; Granger CB; Hanna M; Horowitz J; Hylek EM; Lopes RD; Siegbahn A; Wallentin L;
    Heart; 2016 Apr; 102(7):508-17. PubMed ID: 26839066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.